跳至主要内容
临床试验/NCT03464552
NCT03464552已完成4 期

Role of Oral Celecoxib 200 mg in Reducing Pain Associated With Colposcopic Directed Biopsy: A Randomized Triple-blind Placebo-controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2018年4月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
170
试验地点
1
主要终点
Pain during the procedure

研究概览

简要总结

Women often experience pain and discomfort during colposcopic examination especially at time of colposcopic directed excisional biopsy, pre-procedure anxiety, women pain threshold may also increase pain, woman's cooperation during the procedure is affected by all these factors, which also may hinder the colposcopist from obtaining adequate data and biopsies.

Several pharmacological and non-pharmacological methods have been studied to reduce pain associated colposcopic directed biopsy (CDB). We aim to study the effect of Celecoxib to reduce pain associated with CDB.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females 18-65 years old who undergoing colposcopic directed biopsy

排除标准

  • A known allergy to Celecoxib, aspirin or another NSAID.
  • Active peptic ulceration or gastrointestinal bleeding.
  • Inflammatory bowel disease.
  • Congestive heart failure (NYHA II-IV).
  • Established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.
  • History of neurologic deficit.
  • Known hepatic or renal impairment.
  • Pregnancy.
  • Breast-feeding.
  • Post-hysterectomy.
  • Bleeding disorders.
  • Drug abuse.
  • Cervical and vaginal infection.

研究组 & 干预措施

Celecoxib group

Active Comparator

will receive oral Celecoxib 200 mg capsule (Celebrex®200, Pfizer, USA) once 3 hours before the colposcopic guided biopsy

干预措施: Celecoxib 200mg (Drug)

Celecoxib group

Active Comparator

will receive oral Celecoxib 200 mg capsule (Celebrex®200, Pfizer, USA) once 3 hours before the colposcopic guided biopsy

干预措施: Colposcopic guided biopsy (Procedure)

Placebo group

Placebo Comparator

will receive oral placebo capsule once 3 hours before the colposcopic guided biopsy

干预措施: Colposcopic guided biopsy (Procedure)

Placebo group

Placebo Comparator

will receive oral placebo capsule once 3 hours before the colposcopic guided biopsy

干预措施: Placebo oral capsule (Drug)

结局指标

主要结局

Pain during the procedure

时间窗: Immediately after the first biopsy

Visual analog score in mm on a 10 cm ruler

次要结局

  • Post-procedure pain(At 30 minutes after completing the procedure)
  • Pain at time of vaginal speculum application(At time of introduction of vaginal speculum)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed AA Wali, MD

Lecturer of Obstetrics and Gynecology

Cairo University

研究点 (1)

Loading locations...

相似试验